Does the media prefer SHC or PNTG?

In the previous week, Sotera Health had 5 more articles in the media than The Pennant Group. MarketBeat recorded 17 mentions for Sotera Health and 12 mentions for The Pennant Group. Sotera Health's average media sentiment score of 1.19 beat The Pennant Group's score of 0.88 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 9 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RDNT or PNTG?

In the previous week, The Pennant Group had 9 more articles in the media than RadNet. MarketBeat recorded 12 mentions for The Pennant Group and 3 mentions for RadNet. RadNet's average media sentiment score of 1.04 beat The Pennant Group's score of 0.88 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PNTG or VCYT?

In the previous week, Veracyte had 2 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for Veracyte and 12 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.88 beat Veracyte's score of 0.47 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to CAI or PNTG?

In the previous week, Caris Life Sciences had 2 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for Caris Life Sciences and 12 mentions for The Pennant Group. Caris Life Sciences' average media sentiment score of 0.95 beat The Pennant Group's score of 0.88 indicating that Caris Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PNTG or LFST?

In the previous week, LifeStance Health Group had 8 more articles in the media than The Pennant Group. MarketBeat recorded 20 mentions for LifeStance Health Group and 12 mentions for The Pennant Group. LifeStance Health Group's average media sentiment score of 0.98 beat The Pennant Group's score of 0.88 indicating that LifeStance Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 3 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 8 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

The Pennant Group (PNTG) Competitors

$38.56 -0.50 (-1.27%)

As of 02:49 PM Eastern

Compare

PNTG vs. SHC, RDNT, VCYT, CAI, and LFST

Should you buy The Pennant Group stock or one of its competitors? MarketBeat compares The Pennant Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Pennant Group include Sotera Health (SHC), RadNet (RDNT), Veracyte (VCYT), Caris Life Sciences (CAI), and LifeStance Health Group (LFST).

How does The Pennant Group compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Sotera Health has a net margin of 9.91% compared to The Pennant Group's net margin of 2.93%. Sotera Health's return on equity of 39.73% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
The Pennant Group	2.93%	10.58%	4.37%

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 6.9% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Sotera Health had 5 more articles in the media than The Pennant Group. MarketBeat recorded 17 mentions for Sotera Health and 12 mentions for The Pennant Group. Sotera Health's average media sentiment score of 1.19 beat The Pennant Group's score of 0.88 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	9 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health presently has a consensus price target of $20.88, suggesting a potential upside of 10.72%. The Pennant Group has a consensus price target of $41.00, suggesting a potential upside of 6.31%. Given Sotera Health's higher probable upside, equities research analysts clearly believe Sotera Health is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.62	$77.94M	$0.41	45.99
The Pennant Group	$947.71M	1.41	$29.58M	$0.85	45.37

Sotera Health has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

Summary

Sotera Health beats The Pennant Group on 14 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to RadNet?

RadNet (NASDAQ:RDNT) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

RadNet has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 6.9% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

RadNet currently has a consensus target price of $87.43, suggesting a potential upside of 24.49%. The Pennant Group has a consensus target price of $41.00, suggesting a potential upside of 6.31%. Given RadNet's higher possible upside, analysts clearly believe RadNet is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

In the previous week, The Pennant Group had 9 more articles in the media than RadNet. MarketBeat recorded 12 mentions for The Pennant Group and 3 mentions for RadNet. RadNet's average media sentiment score of 1.04 beat The Pennant Group's score of 0.88 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

The Pennant Group has a net margin of 2.93% compared to RadNet's net margin of -0.66%. The Pennant Group's return on equity of 10.58% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
The Pennant Group	2.93%	10.58%	4.37%

The Pennant Group has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.71	-$18.65M	-$0.18	N/A
The Pennant Group	$947.71M	1.41	$29.58M	$0.85	45.37

Summary

The Pennant Group beats RadNet on 11 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to Veracyte?

The Pennant Group (NASDAQ:PNTG) and Veracyte (NASDAQ:VCYT) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

Veracyte has lower revenue, but higher earnings than The Pennant Group. Veracyte is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.41	$29.58M	$0.85	45.37
Veracyte	$517.15M	7.28	$66.35M	$1.41	33.22

85.9% of The Pennant Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 1.6% of Veracyte shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

The Pennant Group currently has a consensus price target of $41.00, suggesting a potential upside of 6.31%. Veracyte has a consensus price target of $54.33, suggesting a potential upside of 15.99%. Given Veracyte's higher possible upside, analysts clearly believe Veracyte is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Veracyte	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

In the previous week, Veracyte had 2 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for Veracyte and 12 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.88 beat Veracyte's score of 0.47 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

Veracyte has a net margin of 20.37% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.58% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.93%	10.58%	4.37%
Veracyte	20.37%	9.26%	8.61%

The Pennant Group has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.95, indicating that its share price is 95% more volatile than the broader market.

Summary

Veracyte beats The Pennant Group on 9 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

Caris Life Sciences has a net margin of 10.62% compared to The Pennant Group's net margin of 2.93%. Caris Life Sciences' return on equity of 19.12% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	10.62%	19.12%	9.64%
The Pennant Group	2.93%	10.58%	4.37%

Caris Life Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Caris Life Sciences currently has a consensus target price of $26.33, indicating a potential upside of 18.86%. The Pennant Group has a consensus target price of $41.00, indicating a potential upside of 6.31%. Given Caris Life Sciences' higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

The Pennant Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	7.71	-$68.09M	-$7.61	N/A
The Pennant Group	$947.71M	1.41	$29.58M	$0.85	45.37

In the previous week, Caris Life Sciences had 2 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for Caris Life Sciences and 12 mentions for The Pennant Group. Caris Life Sciences' average media sentiment score of 0.95 beat The Pennant Group's score of 0.88 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	9 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.9% of The Pennant Group shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by insiders. Comparatively, 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Caris Life Sciences beats The Pennant Group on 9 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to LifeStance Health Group?

The Pennant Group (NASDAQ:PNTG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

The Pennant Group has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market.

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

The Pennant Group has a net margin of 2.93% compared to LifeStance Health Group's net margin of 1.55%. The Pennant Group's return on equity of 10.58% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.93%	10.58%	4.37%
LifeStance Health Group	1.55%	1.56%	1.07%

The Pennant Group has higher earnings, but lower revenue than LifeStance Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.41	$29.58M	$0.85	45.37
LifeStance Health Group	$1.42B	2.96	$9.66M	$0.06	181.42

The Pennant Group presently has a consensus price target of $41.00, indicating a potential upside of 6.31%. LifeStance Health Group has a consensus price target of $11.63, indicating a potential upside of 6.80%. Given LifeStance Health Group's higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, LifeStance Health Group had 8 more articles in the media than The Pennant Group. MarketBeat recorded 20 mentions for LifeStance Health Group and 12 mentions for The Pennant Group. LifeStance Health Group's average media sentiment score of 0.98 beat The Pennant Group's score of 0.88 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	8 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

The Pennant Group beats LifeStance Health Group on 10 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PNTG vs. The Competition

Export

Metric	The Pennant Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.34B	$9.95B	$6.96B	$12.95B
Dividend Yield	N/A	2.55%	2.59%	9.93%
P/E Ratio	42.86	27.23	270.83	25.99
Price / Sales	1.41	4.80	663.11	111.01
Price / Cash	30.28	127.28	71.89	50.37
Price / Book	3.56	5.18	13.19	6.22
Net Income	$29.58M	$309.96M	$3.45B	$342.55M
7 Day Performance	-4.35%	1.59%	4.32%	4.17%
1 Month Performance	-2.86%	-0.57%	-1.87%	-1.15%
1 Year Performance	59.89%	24.69%	76.76%	22.24%

The Pennant Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PNTG The Pennant Group	3.9555 of 5 stars	$38.57 -1.3%	$41.00 +6.3%	+75.5%	$1.34B	$947.71M	42.86	9,700	News Coverage Earnings Report Analyst Upgrade
SHC Sotera Health	3.1539 of 5 stars	$17.53 -1.3%	$20.25 +15.5%	+71.0%	$5.06B	$1.16B	42.76	3,000	Trending News Earnings Report Analyst Forecast
RDNT RadNet	3.5154 of 5 stars	$63.37 +0.2%	$87.43 +38.0%	+28.7%	$4.97B	$2.04B	N/A	11,264	Positive News Upcoming Earnings
VCYT Veracyte	3.7842 of 5 stars	$55.71 +0.1%	$55.88 +0.3%	+92.5%	$4.44B	$517.15M	51.11	790	Analyst Forecast
CAI Caris Life Sciences	4.8687 of 5 stars	$15.59 flat	$26.11 +67.5%	N/A	$4.41B	$348.89M	N/A	1,846	News Coverage Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PNTG) was last updated on 8/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Pennant Group (PNTG) Competitors

PNTG vs. SHC, RDNT, VCYT, CAI, and LFST

How does The Pennant Group compare to Sotera Health?

Summary

How does The Pennant Group compare to RadNet?

Summary

How does The Pennant Group compare to Veracyte?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Summary

How does The Pennant Group compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Pennant Group (PNTG) Competitors

PNTG vs. SHC, RDNT, VCYT, CAI, and LFST

How does The Pennant Group compare to Sotera Health?

Is SHC or PNTG more profitable?

Do institutionals & insiders have more ownership in SHC or PNTG?

Does the media prefer SHC or PNTG?

Do analysts prefer SHC or PNTG?

Which has higher valuation and earnings, SHC or PNTG?

Which has more risk & volatility, SHC or PNTG?

Summary

How does The Pennant Group compare to RadNet?

Which has more volatility and risk, RDNT or PNTG?

Do insiders & institutionals hold more shares of RDNT or PNTG?

Do analysts recommend RDNT or PNTG?

Does the media prefer RDNT or PNTG?

Is RDNT or PNTG more profitable?

Which has better earnings and valuation, RDNT or PNTG?

Summary

How does The Pennant Group compare to Veracyte?

Which has higher valuation & earnings, PNTG or VCYT?

Do institutionals & insiders have more ownership in PNTG or VCYT?

Do analysts prefer PNTG or VCYT?

Does the media favor PNTG or VCYT?

Is PNTG or VCYT more profitable?

Which has more volatility & risk, PNTG or VCYT?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Is CAI or PNTG more profitable?

Which has more volatility & risk, CAI or PNTG?

Do analysts recommend CAI or PNTG?

Which has stronger valuation and earnings, CAI or PNTG?

Does the media refer more to CAI or PNTG?

Do insiders and institutionals believe in CAI or PNTG?

Summary

How does The Pennant Group compare to LifeStance Health Group?

Which has more risk and volatility, PNTG or LFST?

Do insiders & institutionals believe in PNTG or LFST?

Is PNTG or LFST more profitable?

Which has better valuation & earnings, PNTG or LFST?

Do analysts prefer PNTG or LFST?

Does the media refer more to PNTG or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools